Samsung BioLogics Co (XKRX:207940) Other Long Term Assets : ₩415,394 Mil (As of Dec. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Other Long Term Assets?

Samsung BioLogics Co's other long-term assets for the quarter that ended in Dec. 2024 was ₩415,394 Mil.

Samsung BioLogics Co's quarterly other long-term assets increased from Jun. 2024 (₩354,265 Mil) to Sep. 2024 (₩387,327 Mil) and increased from Sep. 2024 (₩387,327 Mil) to Dec. 2024 (₩415,394 Mil).

Samsung BioLogics Co's annual other long-term assets increased from Dec. 2022 (₩291,635 Mil) to Dec. 2023 (₩349,698 Mil) and increased from Dec. 2023 (₩349,698 Mil) to Dec. 2024 (₩415,394 Mil).

Samsung BioLogics Co Other Long Term Assets Historical Data

The historical data trend for Samsung BioLogics Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Other Long Term Assets Chart

Samsung BioLogics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Long Term Assets

Get a 7-Day Free Trial

2,888,781.80

2,886,976.37

291,634.67

349,697.68

415,393.66

Samsung BioLogics Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Long Term Assets	Get a 7-Day Free Trial															349,697.68	337,818.39	354,264.77	387,326.70	415,393.66

Samsung BioLogics Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Samsung BioLogics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR

Website

https://www.samsungbiologics.com

Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines